Published in Oral Dis on September 24, 2012
Current treatment of oral candidiasis: A literature review. J Clin Exp Dent (2014) 0.86
The denture box. An aid to denture hygiene. Br Dent J (2015) 0.81
Killer system: a simple method for differentiating Candida albicans strains. J Clin Microbiol (1983) 8.05
Direct allelic variation scanning of the yeast genome. Science (1998) 5.90
Risk of oral squamous cell carcinoma in 402 patients with oral lichen planus: a follow-up study in an Italian population. Oral Oncol (2004) 2.46
Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria. Nat Biotechnol (2000) 1.79
Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity. Nat Biotechnol (1997) 1.75
Urban legends: recurrent aphthous stomatitis. Oral Dis (2011) 1.68
Oral acanthosis nigricans, tripe palms and sign of leser-trélat in a patient with gastric adenocarcinoma. Int J Dermatol (2004) 1.62
Number V Oral lichen planus: clinical features and management. Oral Dis (2005) 1.61
Neonatal mouse immunity against group B streptococcal infection by maternal vaccination with recombinant anti-idiotypes. Nat Med (1998) 1.54
Multicenter comparative evaluation of six commercial systems and the national committee for clinical laboratory standards m27-a broth microdilution method for fluconazole susceptibility testing of Candida species. J Clin Microbiol (2002) 1.51
Ciclosporin vs. clobetasol in the topical management of atrophic and erosive oral lichen planus: a double-blind, randomized controlled trial. Br J Dermatol (2006) 1.50
Yeast killer systems. Clin Microbiol Rev (1997) 1.47
Course of oral lichen planus: a retrospective study of 808 northern Italian patients. Oral Dis (2009) 1.44
Personalized antifungal susceptibility testing. J Antimicrob Chemother (1999) 1.38
Blastoschizomyces capitatus: an emerging cause of invasive fungal disease in leukemia patients. Rev Infect Dis (1990) 1.34
Studies on the epidemiology of Aspergillus fumigatus infections in a university hospital. Eur J Epidemiol (1989) 1.29
Reevaluation of the yeast killer phenomenon. J Clin Microbiol (1986) 1.28
Update on diabetes mellitus and related oral diseases. Oral Dis (2004) 1.27
Time-varying mechanical behavior of multijointed arm in man. J Neurophysiol (1993) 1.23
Use of killer toxins for computer-aided differentiation of Candida albicans strains. Mycopathologia (1985) 1.22
Hepatitis C virus infection and lichen planus: a systematic review with meta-analysis. Oral Dis (2010) 1.22
Serological analysis of dermatophyte isolates with monoclonal antibodies produced against Microsporum canis. J Clin Microbiol (1985) 1.17
Strain differentiation of pathogenic yeasts by the killer system. Mycopathologia (1984) 1.16
Oral mucosal dysplastic lesions and early squamous cell carcinomas: underdiagnosis from incisional biopsy. Oral Dis (2003) 1.10
Antibodies, killer toxins and antifungal immunoprotection: a lesson from nature? Immunol Today (1997) 1.07
Pharmacology: potency rankings. Br Dent J (2014) 1.07
Oral fungal infections: an update for the general practitioner. Aust Dent J (2010) 1.06
Nosocomial outbreak of systemic candidosis associated with parenteral nutrition. Infect Control Hosp Epidemiol (1990) 1.05
Antibody and/or cell-mediated immunity, protective mechanisms in fungal disease: an ongoing dilemma or an unnecessary dispute? Med Mycol (1998) 1.04
Urban legends series: lichen planus. Oral Dis (2012) 1.04
Pneumocystis carinii: an atypical fungal micro-organism. J Med Vet Mycol (1997) 1.03
Periodontal status in oral mucous membrane pemphigoid: initial results of a case-control study. Oral Dis (2011) 1.03
Imported paracoccidioidomycosis: a public health problem in non-endemic areas. Eur J Epidemiol (1985) 1.02
Electron microscopy studies of human intestinal spirochetes. Eur J Epidemiol (1987) 1.00
Invasive Fusarium solani infections in patients with acute leukemia. Rev Infect Dis (1988) 1.00
Application of DNA typing methods and genetic analysis to epidemiology and taxonomy of Saccharomyces isolates. J Clin Microbiol (1997) 0.99
Clinical and microbiological studies of periodontal disease in Sjögren syndrome patients. J Clin Periodontol (2002) 0.97
Stress proteins in fungal diseases. Med Mycol (1998) 0.97
Initial case of Candida dubliniensis infection from Asia: non-mucosal infection. Med Mycol (2000) 0.97
Specific and common antigenic determinants of Candida albicans isolates detected by monoclonal antibody. J Clin Microbiol (1986) 0.96
Antibodies as crypts of antiinfective and antitumor peptides. Curr Med Chem (2009) 0.95
Production and characterization of yeast killer toxin monoclonal antibodies. J Clin Microbiol (1987) 0.95
Interventions for treating oral lichen planus: a systematic review. Br J Dermatol (2012) 0.94
Transient reversal of the stretch reflex in human arm muscles. J Neurophysiol (1991) 0.94
Visuomotor transformations for reaching to memorized targets: a PET study. Neuroimage (1997) 0.93
Exoantigen test for identification of Petriellidium boydii cultures. J Clin Microbiol (1981) 0.92
Antifungal and antitumor activities of a monoclonal antibody directed against a stress mannoprotein of Candida albicans. Curr Mol Med (2005) 0.92
Urban legends series: oral leukoplakia. Oral Dis (2013) 0.91
Mycobactericidal activity of human natural, monoclonal, and recombinant yeast killer toxin-like antibodies. J Infect Dis (1998) 0.90
Exoantigen Studies of Sporothrix schenckii, Ceratocystis minor, and Graphium penicilliodes cultures. J Clin Microbiol (1982) 0.90
Identification and serotyping of Microsporum canis isolates by monoclonal antibodies. J Clin Microbiol (1986) 0.89
In vitro antifungal susceptibility to six antifungal agents of 229 Candida isolates from patients with diabetes mellitus. Oral Microbiol Immunol (2006) 0.89
Internal models of limb geometry in the control of hand compliance. J Neurosci (1992) 0.89
Effect of oestrogen replacement on bone metabolism and cytokines in surgical menopause. Clin Rheumatol (1995) 0.88
Comparison between fine needle aspiration cytology (FNAC) and core needle biopsy (CNB) in the diagnosis of breast lesions. G Chir (2014) 0.87
[Variations of metabolism of 5-hydroxytryptamine in chronic bronchopneumonic diseases]. Minerva Med (1966) 0.87
Hepatitis C virus-associated oral lichen planus: no influence from hepatitis G virus co-infection. J Oral Pathol Med (2000) 0.87
Mapping of beta-1,2-linked oligomannosidic epitopes among glycoconjugates of Candida species. Microbiology (1995) 0.87
The isolation, identification and molecular analysis of Candida spp. isolated from the oral cavities of patients with diabetes mellitus. Oral Microbiol Immunol (2002) 0.87
In vitro activity of monoclonal and recombinant yeast killer toxin-like antibodies against antibiotic-resistant gram-positive cocci. Mol Med (2000) 0.87
Urban legend series: mucous membrane pemphigoid. Oral Dis (2013) 0.87
Oral lichen planus and hepatitis C virus (HCV) infection: is there a relationship? A report of 10 cases. J Oral Pathol Med (1994) 0.86
Management of oral lichen planus. Am J Clin Dermatol (2001) 0.86
Verrucous oral carcinoma: clinical findings and treatment outcomes in 74 patients in Northwest Italy. Minerva Stomatol (2008) 0.86
Update on mucous membrane pemphigoid: a heterogeneous immune-mediated subepithelial blistering entity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1999) 0.86
Urban legends series: oral manifestations of HIV infection. Oral Dis (2013) 0.86
Altered expression of alpha 6 integrin subunit in oral squamous cell carcinoma and oral potentially malignant lesions. Oral Oncol (1998) 0.85
Oral cancer awareness for the general practitioner: new approaches to patient care. Aust Dent J (2008) 0.85
A blinded randomized controlled trial comparing lignocaine and placebo administration to the palate for removal of maxillary third molars. Int J Oral Maxillofac Surg (2007) 0.85
Biotyping of bacterial isolates using the yeast killer system. Eur J Epidemiol (1989) 0.85
Production of carcinogenic acetaldehyde by Candida albicans from patients with potentially malignant oral mucosal disorders. J Oral Pathol Med (2012) 0.84
Biotyping of aerobic actinomycetes by modified killer system. Eur J Epidemiol (1988) 0.84
Hansenula anomala killer toxin induces secretion and severe acute injury in the rat intestine. Gastroenterology (1995) 0.84
Potential therapeutic effect of yeast killer toxin. Mycopathologia (1986) 0.84
Topical corticosteroids in dental practice. Aust Dent J (2005) 0.83
Protective antifungal yeast killer toxin-like antibodies. Curr Mol Med (2005) 0.83
Killer factor interference in mixed opportunistic yeast cultures. Mycopathologia (1996) 0.83
Evaluation of the Abbott LCx Mycobacterium tuberculosis assay in comparison with culture methods in selected Italian patients. New Microbiol (1998) 0.83
HCV genotypes in Italian patients with HCV-related oral lichen planus. J Oral Pathol Med (1997) 0.83
Urban legends: pemphigus vulgaris. Oral Dis (2012) 0.82
Oral manifestations associated with human immunodeficiency virus infection in a Spanish population. J Oral Pathol Med (1996) 0.82
Systemic and topical corticosteroid treatment of oral lichen planus: a comparative study with long-term follow-up. J Oral Pathol Med (2003) 0.82
The yeast killer phenomenon: a hypothetical way to control Pneumocystis carinii pneumonia. Med Hypotheses (1994) 0.81
Quantitation and morphotyping of Candida albicans from healthy mouths and from mouths affected by erythematous candidosis. J Med Vet Mycol (1992) 0.81
Engineered killer mimotopes: new synthetic peptides for antimicrobial therapy. Curr Med Chem (2004) 0.81
A microautomated dilution method for susceptibility testing with antifungal drugs. Mycopathologia (1984) 0.81
Survey of human pathogenic actinomycetes and fungi in soil from Rome and other Italian areas. Mycopathologia (1981) 0.81
Analysis of the strain relatedness of oral Candida albicans in patients with diabetes mellitus using polymerase chain reaction-fingerprinting. Oral Microbiol Immunol (2006) 0.81
[Oral candidiasis as the first manifestation of HIV (human immunodeficiency virus) infection. An analysis of 2 cases]. Minerva Stomatol (1992) 0.81
Topical clobetasol in the treatment of atrophic-erosive oral lichen planus: a randomized controlled trial to compare two preparations with different concentrations. J Oral Pathol Med (2008) 0.81
In vitro evaluation of virulence attributes of Candida spp. isolated from patients affected by diabetes mellitus. Oral Microbiol Immunol (2006) 0.81
Effect of a killer toxin of Pichia anomala to Pneumocystis. Perspectives in the control of pneumocystosis. FEMS Immunol Med Microbiol (1998) 0.81
Reactivity of Candida albicans germ tubes with salivary secretory IgA. J Dent Res (1996) 0.80
Use of DNA fingerprinting and biotyping methods to study a Candida albicans outbreak in a neonatal intensive care unit. Pediatr Infect Dis J (1994) 0.80
Structural and functional characterization of the porcine proline-rich antifungal peptide SP-B isolated from salivary gland granules. J Pept Sci (2008) 0.80
The development and validation of a rapid genetic method for species identification and genotyping of medically important fungal pathogens using high-resolution melting curve analysis. Mol Oral Microbiol (2014) 0.80
Inhibitory effect of a Pichia anomala killer toxin on Pneumocystis carinii infectivity to the SCID mouse. Parasitol Res (1996) 0.80
[An increase in gingival volume induced by drugs (phenytoin, cyclosporine and calcium antagonists). A review of the literature]. Minerva Stomatol (1998) 0.80